|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 138 studies with search of: | Emtricitabina OR Emtriva[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Raltegravir Activity In Lymphoid Tissues
|
||||
| 2 | Active, not recruiting |
Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 (QUAD) Versus Atripla(R) in HIV Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 3 | Completed |
An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
|
||||
| 4 | Completed |
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
|
||||
| 5 | Recruiting |
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
|
||||
| 6 | Active, not recruiting |
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
|
||||
| 7 | Active, not recruiting |
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
|
||||
| 8 | Recruiting |
Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
|
||||
| 9 | Completed |
Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
|
||||
| 10 | Active, not recruiting |
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
|
||||
| 11 | Active, not recruiting |
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
|
||||
| 12 | Recruiting |
Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
|
||||
| 13 | Recruiting |
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
|
||||
| 14 | Recruiting |
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-Infected Patients With Tuberculosis
|
||||
| 15 | Recruiting |
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
|
||||
| 16 | Recruiting |
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
|
||||
| 17 | Recruiting |
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
|
||||
| 18 | Completed |
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection
|
||||
| 19 | Active, not recruiting |
Efficacy of Tenofovir and Emtricitabine in ARV-Naive Patients With HIV/HBV co-Infection
|
||||
| 20 | Active, not recruiting |
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|